Related Experiment Video
Updated: Aug 5, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
High prevalence of peripheral and carotid artery disease in patients with interstitial lung diseases
Max Jonathan Stumpf1, Max Fabian Fleddermann1, Marina Michaela Luise Wirtz1
1Department of Internal Medicine II, Cardiology, Pneumology, and Angiology, University Hospital Bonn, Germany.
Insights
Interstitial lung diseases (ILD) significantly increase the risk of peripheral artery disease (PAD), particularly in progressive fibrosing ILD. This highlights ILD as an independent risk factor for atherosclerosis.
Area of Science:
- Pulmonology
- Cardiology
- Vascular Medicine
Background:
- Interstitial lung diseases (ILD) share common pathways like pulmonary fibrosis and restrictive lung disease.
- Comorbidities, not ILD itself, often lead to premature death.
- Peripheral artery disease (PAD) is a frequent comorbidity in chronic lung diseases.
Purpose of the Study:
- To determine the prevalence of PAD in patients with ILD.
- To compare PAD incidence between progressive fibrosing ILD (PF-ILD) and non-progressive fibrosing ILD (nPF-ILD) patients.
Main Methods:
- A study included 97 ILD patients and 30 controls.
- Participants underwent angiological and pneumological diagnostics, including ankle-brachial index and duplex sonography.
- ILD patients were categorized into PF-ILD and nPF-ILD groups.
Main Results:
- Both PF-ILD and nPF-ILD groups showed significantly higher atherosclerotic lesion incidence than controls (p<0.001).
- PAD was observed in 100% of PF-ILD patients and 73% of nPF-ILD patients.
- Age-adjusted regression analyses confirmed these findings.
Conclusions:
- ILD is an independent risk factor for atherosclerosis.
- PF-ILD patients exhibit more severe atherosclerosis compared to nPF-ILD patients.
- Mechanisms may involve cardiovascular risk, systemic inflammation, and chronic hypoxemia.
Abstract:
Background: Interstitial lung diseases (ILD) are a heterogenous group of diseases, which have pulmonary fibrosis, restrictive lung disease, and decreased diffusion capacity as a common final path. Premature death frequently results not from ILD itself but from comorbidities. Peripheral artery disease (PAD) is a common comorbid disease in different chronic lung diseases. The focus of the present study is to clarify the prevalence of PAD in ILD. Patients and methods: A total of 97 patients with ILD and 30 controls were included in the study. Patients with ILD were subdivided into two groups according to the progression of pulmonary fibrosis: progressive fibrosing and non-progressive fibrosing ILD (PF-ILD and nPF-ILD, respectively). All participants underwent standard angiological and pneumological diagnostic procedures including six-minute walking test, measurement of ankle-brachial-index, and colour-coded duplex sonography. Results: We observed no relevant differences in the baseline characteristics except age. Both, PF-ILD and nPF-ILD patients, presented with a highly increased incidence of atherosclerotic lesions compared to the control group (p<0.001). PAD was present in all patients with PF-ILD and in 73% of patients with nPF-ILD. These results were confirmed by age-adjusted regression analyses. Conclusions: The present results indicate that ILD is an independent risk factor for atherosclerosis. Patients with PF-ILD are more severely affected than nPF-ILD patients with age as a confounding variable. Atherogenesis in ILD may be mediated by increased cardiovascular risk, systemic inflammation and chronic hypoxemia.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Peripheral Artery Disease III: Interprofessional Care

